A detailed history of Ground Swell Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ground Swell Capital, LLC holds 293 shares of LLY stock, worth $233,131. This represents 0.23% of its overall portfolio holdings.

Number of Shares
293
Holding current value
$233,131
% of portfolio
0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $226,237 - $281,285
293 New
293 $259,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $170,619 - $212,036
-727 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $163,465 - $202,862
727 New
727 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.